businesspress24.com - Cadus Reports Third Quarter 2013 Results
 

Cadus Reports Third Quarter 2013 Results

ID: 1279769

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 11/05/13 -- (OTCBB: KDUS) announced today financial results for the third quarter ended September 30, 2013.

Revenues were $0 for the third quarter of 2013 and for the same period in 2012. Net loss for the third quarter of 2013 was $72,397, compared to a net loss of $211,032 for the same period in 2012. Basic net loss per share was $0.01 for the third quarter of 2013, compared to a basic net loss per share of $0.02 for the same period in 2012.

Revenues were $0 for the first nine months of 2013 and for the same period in 2012. Net loss for the first nine months of 2013 was $315,326, compared to a net loss of $522,149 for the same period in 2012. Basic net loss per share for the first nine months of 2013 was $0.02, compared to a basic net loss per share of $0.04 for the same period in 2012.

As of October 31, 2013, Cadus had 13,144,040 shares outstanding.

This press release may contain forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's annual report on Form 10-K for the year ended December 31, 2012. These include risks and uncertainties relating to the company's ability to license its technologies to third parties, the company's ability to acquire and operate other companies or assets, the company's capital needs and uncertainty of future funding, the company's history of operating losses, the unpredictability of patent protection and the risk of obsolescence of the company's technologies.

(Tables Follow)







David Blitz
212-575-7800




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  iBio Appoints Senior Management for New Business Unit, iBio Brazil
Peregrine Pharmaceuticals to Present at Credit Suisse 2013 Healthcare Conference
Bereitgestellt von Benutzer: Marketwired
Datum: 05.11.2013 - 14:10 Uhr
Sprache: Deutsch
News-ID 1279769
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 96 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cadus Reports Third Quarter 2013 Results
"
steht unter der journalistisch-redaktionellen Verantwortung von

Cadus (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cadus



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 99


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.